Aransado, Jerayzah .

HRN: 26-93-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/25/2025
07/02/2025
IV
900mg
Q8hrs
S/P Vaginal Exploration
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines